Developed through Harvard’s Blavatnik Biomedical Accelerator, an innovative immune-silent stem cell technology could lead to novel cell therapies to treat “any patient with any disease.”

At the Graduate School of Design, the exhibit “Urban Intermedia” stands as “an experiment and the beginning of an ongoing discussion on new kinds of practices around the study of cities,” said co-curator Eve Blau.